% | $
Quotes you view appear here for quick access.

Zalicus AŞ Message Board

  • italian30_2000 italian30_2000 Nov 4, 2013 11:43 AM Flag

    JN's 3 Un-named "Experts" v. Elsevier BI Therapeutic Area Partnerships independant panel of experts?

    This seems a bit funny that the market is responding so strongly to this guy's tweet based upon unvetted and unidentified sources who's credentials or track records of successfully evaluating the validity of concepts or potential efficacy of compounds is unsubstantiated. On the other hand, we have an market recognized source of independant, industry specific and proven experts who have a vetted and substantiated history of successfully evaluating the validity of concepts and the potential efficacy of compounds identifying Z-160 as a Top Project to watch in the Nueroscience field and were kind enough to lay out the outline of the criteria they used in their determination. Most interesting is that Z-160 was selected over "hundreds of compounds...who's potential of becoming a future product" was weighed!

    Who ever said the market was rational?!

    SortNewest  |  Oldest  |  Most Replied Expand all replies